Nov 18, 09
|
| NEW STORY |
| 09:45 ET |
CEL-SCI Announces Start of First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
|
|
Nov 09, 09
|
| 09:40 ET |
CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response
|
|
Nov 06, 09
|
| 09:45 ET |
CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
|
|
Oct 26, 09
|
| 09:55 ET |
CEL-SCI Corporation Strengthens Balance Sheet Through Receipt of $10 Million From Warrant Exercises
|
|
Oct 19, 09
|
| 09:45 ET |
CEL-SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL-2000 Has Potential to Slow Damage Caused by Rheumatoid Arthritis
|
|
Oct 05, 09
|
| 14:30 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Sep 23, 09
|
| 10:18 ET |
CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
|
|
Sep 16, 09
|
| 13:10 ET |
CEL-SCI Corporation to Raise $20 Million in Registered Direct Offering
|
|
| 07:30 ET |
CEL-SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients
|
|
Sep 02, 09
|
| 09:00 ET |
CEL-SCI Corporation Announces Elimination of $8.3 Million Convertible Notes
|
|
Aug 20, 09
|
| 09:10 ET |
CEL-SCI Signs Definitive Agreement to Raise $4.4 Million in Registered Direct Offering
|
|
Aug 18, 09
|
| 10:09 ET |
CEL-SCI Expands H1N1 Flu Virus Work
|
|
Aug 14, 09
|
| 16:58 ET |
CEL-SCI Corporation Reports Third Quarter 2009 Financial Results
|
|
Jul 10, 09
|
| 08:30 ET |
CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
|
|
Jul 07, 09
|
| 09:45 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jun 30, 09
|
| 12:28 ET |
CEL-SCI Completes $5.85 Million Registered Direct Offering
|
|
Jun 24, 09
|
| 09:25 ET |
CEL-SCI Files Patent Application to Support Company's Treatment for More Virulent Strain of H1N1 Swine and Other Influenza Viruses
|
|
| 09:20 ET |
CEL-SCI Signs Definitive Agreement to Raise $5 Million in Registered Direct Offering
|
|
Jun 22, 09
|
| 18:50 ET |
CEL-SCI Posts New Corporate Presentation to Website
|
|
Jun 16, 09
|
| 09:00 ET |
CEL-SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annual Aseptic Processing of Sterile Drug Products Conference
|
|
Jun 09, 09
|
| 09:35 ET |
CEL-SCI Expands Testing of Its Vaccine to Determine Efficacy Against More Virulent Strain of H1N1 Swine and Other Influenza Viruses
|
|
Jun 05, 09
|
| 08:59 ET |
CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas
|
|
May 26, 09
|
| 09:00 ET |
CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology
|
|
May 15, 09
|
| 15:49 ET |
CEL-SCI Corporation Reports 2009 Second Fiscal Quarter Financial Results
|
|
Apr 28, 09
|
| 09:37 ET |
CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies
|
|
Apr 27, 09
|
| 10:00 ET |
CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
|
|
Apr 14, 09
|
| 14:09 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Mar 10, 09
|
| 08:30 ET |
CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
|
|
Mar 09, 09
|
| 09:30 ET |
CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa
|
|
Feb 20, 09
|
| 09:03 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jan 14, 09
|
| 09:15 ET |
CEL-SCI Corporation Announces 2008 Financial Results
|
|
Jan 07, 09
|
| 09:35 ET |
CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine
|
|
Dec 12, 08
|
| 10:11 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Dec 03, 08
|
| 09:45 ET |
Updated Pictures of CEL-SCI Manufacturing Facility Available Online
|
|
Nov 14, 08
|
| 10:00 ET |
New Data Points to Long Lasting Beneficial Effects of CEL-SCI's Rheumatoid Arthritis Vaccine
|
|
Nov 03, 08
|
| 09:45 ET |
CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
|
|
Oct 09, 08
|
| 09:45 ET |
CEL-SCI Takes Delivery of New Manufacturing Facility
|
|
Oct 07, 08
|
| 10:34 ET |
CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
|
|
Sep 16, 08
|
| 09:40 ET |
CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
|
|
Sep 05, 08
|
| 09:45 ET |
Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
|
|
Aug 20, 08
|
| 10:39 ET |
CEL-SCI CORPORATION Releases Letter to Shareholders
|
|
| 09:15 ET |
CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
|
|
Aug 19, 08
|
| 11:00 ET |
CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
|
|
Jun 17, 08
|
| 09:33 ET |
CEL-SCI Announces Discovery of Novel Compound for the Treatment of Rheumatoid Arthritis
|
|
Jun 09, 08
|
| 09:30 ET |
CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
|
|
Jun 04, 08
|
| 09:00 ET |
CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
|
|
May 16, 08
|
| 13:00 ET |
CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
|
|
Mar 03, 08
|
| 11:00 ET |
CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
|
|
Feb 14, 08
|
| 16:15 ET |
CEL-SCI Corporation Reports First Quarter Financial Results
|
|
Jan 28, 08
|
| 09:25 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jan 14, 08
|
| 09:00 ET |
CEL-SCI Corporation Announces 2007 Financial Results
|
|
Nov 09, 07
|
| 09:00 ET |
CEL-SCI Corporation Announces Adoption of Shareholder Rights Plan
|
|
Oct 30, 07
|
| 09:00 ET |
CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
|
|
Oct 29, 07
|
| 09:00 ET |
Comprehensive Review of Cancer Immnunotherapies Published By CEL-SCI
|
|
Oct 18, 07
|
| 09:45 ET |
CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
|
|
Sep 19, 07
|
| 09:30 ET |
CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
|
|
Sep 17, 07
|
| 13:18 ET |
CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
|
|
Sep 10, 07
|
| 09:45 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Aug 20, 07
|
| 09:15 ET |
CEL-SCI to Present at the Noble Financial Conference
|
|
Aug 14, 07
|
| 09:35 ET |
CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
|
|
Aug 13, 07
|
| 17:45 ET |
CEL-SCI Corporation Reports Third Quarter 2007 Financial Results
|
|
Jun 13, 07
|
| 09:40 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jun 12, 07
|
| 09:45 ET |
CEL-SCI Receives US FDA Orphan Drug Designation for Its Cancer Drug Multikine(R)
|
|
May 29, 07
|
| 10:23 ET |
CEL-SCI CEO to Present at Dutton Associates' 'Recognizing Opportunity' SmallCap Conference in San Francisco May 30
|
|
May 23, 07
|
| 09:30 ET |
CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
|
|
May 21, 07
|
| 09:30 ET |
CEL-SCI Presents Long-Term Cancer Survival Data With Multikine(R)
|
|
May 14, 07
|
| 17:00 ET |
CEL-SCI Corporation Reports Second Quarter 2007 Financial Results
|
|
| 09:15 ET |
CEL-SCI to Present at Rodman & Renshaw 4th Annual Global Healthcare Conference
|
|
May 07, 07
|
| 09:00 ET |
CEL-SCI to Present at BIO 2007 Business Forum
|
|
May 01, 07
|
| 09:30 ET |
CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
|
|
Apr 26, 07
|
| 10:50 ET |
CEL-SCI Announces Issuance of U.S. Patent for New Platform Technology to Treat Immune System-Based Diseases
|
|
Apr 24, 07
|
| 09:40 ET |
CEL-SCI Announces Important Publication by Two of its Key Scientists
|
|
Apr 18, 07
|
| 09:48 ET |
CEL-SCI Announces $15 Million Financing
|
|
Mar 19, 07
|
| 10:00 ET |
CEL-SCI to Present at Major Cancer Conference
|
|
Mar 14, 07
|
| 10:00 ET |
CEL-SCI CEO to Present at the Biotech / Pharma / Healthcare On-Line Forum
|
|
Feb 14, 07
|
| 17:00 ET |
CEL-SCI CORPORATION Reports First Quarter Financial Results
|
|
Feb 09, 07
|
| 09:15 ET |
CEL-SCI to Present at BIO CEO & Investor 2007 Conference
|
|
Feb 05, 07
|
| 13:07 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jan 22, 07
|
| 09:30 ET |
CEL-SCI Announces $15 Million Commitment For Cancer Drug Manufacturing Facility
|
|
Jan 17, 07
|
| 08:30 ET |
CEL-SCI Corporation Announces 2006 Financial Results
|
|
Jan 16, 07
|
| 10:00 ET |
CEL-SCI Receives Green Light From FDA to Proceed With Phase III Cancer Study
|
|
Dec 19, 06
|
| 11:00 ET |
CEL-SCI Announces the Development and Patenting of a New Platform Technology to Treat Immune System-Based Diseases
|
|
Nov 10, 06
|
| 09:00 ET |
CEL-SCI CEO to Present at the Life Science Informed Investor Forum
|
|
Oct 17, 06
|
| 09:00 ET |
CEL-SCI Will Hold Annual Meeting in Germany on November 17, 2006
|
|
Sep 26, 06
|
| 10:00 ET |
CEL-SCI CEO Interviewed by Wall Street Reporter
|
|
Sep 22, 06
|
| 11:29 ET |
CEL-SCI CEO Interview Published by SmallCap Network
|
|
Sep 20, 06
|
| 09:40 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Aug 14, 06
|
| 17:25 ET |
CEL-SCI Corporation Reports Third Quarter 2006 Financial Results
|
|
Aug 07, 06
|
| 15:05 ET |
CEL-SCI CEO to Conduct Two Interviews Following Financing Announcement
|
|
| 08:30 ET |
CEL-SCI Corporation Announces $8.3 Million Financing
|
|
Jun 20, 06
|
| 09:00 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jun 19, 06
|
| 15:00 ET |
CEL-SCI to Conduct Live Interview on MN1.com
|
|
Jun 08, 06
|
| 09:35 ET |
CEL-SCI Announces Receipt of Compliance Notice From AMEX
|
|
May 23, 06
|
| 13:15 ET |
CEL-SCI Presents Long-Term Survival Data With Its Anti-Cancer Drug Multikine(R)
|
|
May 19, 06
|
| 09:00 ET |
CEL-SCI Corporation Reports Second Quarter 2006 Financial Results
|
|
May 18, 06
|
| 09:00 ET |
CEL-SCI Corporation Reports First Quarter Financial Results
|
|
May 10, 06
|
| 09:30 ET |
Cancer Survival Data From Multikine to be Presented in May 2006
|
|
May 08, 06
|
| 09:40 ET |
CEL-SCI Corporation Releases Bird (Avian) Flu Letter to Shareholders
|
|
Apr 25, 06
|
| 09:00 ET |
CEL-SCI Corporation Announces 2005 Financial Results
|
|
Apr 20, 06
|
| 09:30 ET |
CEL-SCI Extends Agreement With U.S. Navy for CEL-1000 Drug
|
|
Apr 19, 06
|
| 09:35 ET |
CEL-1000 Peptide Shows Adjuvant Activity with Malaria Vaccines
|
|
Apr 04, 06
|
| 09:45 ET |
CEL-SCI Files Patent for Prevention/Treatment of Bird (Avian) Flu
|
|
Apr 03, 06
|
| 10:00 ET |
CEL-SCI Corporation Releases Bird (Avian) Flu Letter to Shareholders
|
|
Mar 30, 06
|
| 16:10 ET |
CEL-SCI's 10-K in Final Review Phase
|
|
Mar 17, 06
|
| 16:10 ET |
CEL-SCI Requests Additional Time to File 10-K
|
|
Mar 08, 06
|
| 11:46 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Feb 28, 06
|
| 10:28 ET |
CEL-SCI Receives U.S. Patent for Use of L.E.A.P.S(TM) Technology for Autoimmune Conditions and Allergies
|
|
Feb 21, 06
|
| 10:07 ET |
Multikine Treatment Increases Survival in Cancer Patients
|
|
Feb 17, 06
|
| 16:15 ET |
CEL-SCI Receives Notice From Amex Regarding Inability to File 10-Q
|
|
Feb 14, 06
|
| 17:00 ET |
CEL-SCI Provides Estimated Financial Results for First Quarter 2006
|
|
Feb 10, 06
|
| 15:00 ET |
CEL-SCI Raises $1.0 Million in New Equity
|
|
Jan 25, 06
|
| 16:31 ET |
CEL-SCI Receives Notice From AMEX Regarding Inability to File 10-K
|
|
Jan 19, 06
|
| 09:45 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jan 18, 06
|
| 09:00 ET |
CEL-SCI Requests Extension Time to File 10-K With SEC and Distribute Annual Report to Shareholders
|
|
Dec 06, 05
|
| 10:30 ET |
CEL-SCI Answers Questions Regarding Testing Agreement With NIH for Drug Against Avian Flu Virus H5N1
|
|
Dec 05, 05
|
| 07:02 ET |
CEL-SCI Signs Agreement With U.S. Government Institute for Testing of Drug Against Avian Flu Virus H5N1
|
|
Nov 03, 05
|
| 10:34 ET |
CEL-SCI Announces Presentations of L.E.A.P.S.(TM) Technology for Therapeutic Vaccines at 3rd Annual Conference on Vaccines
|
|
Nov 01, 05
|
| 09:30 ET |
CEL-SCI Receives U.S. Patent For CEL-1000 Anti-Infective Drug
|
|
Oct 31, 05
|
| 09:45 ET |
CEL-SCI Announces $5 Million Equity Financing Agreement
|
|
Oct 17, 05
|
| 09:45 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Sep 29, 05
|
| 09:45 ET |
CEL-SCI Receives Funds From Legal Settlement
|
|
Sep 22, 05
|
| 09:00 ET |
CEL-SCI Is Awarded $630,000 in Legal Settlement
|
|
Aug 23, 05
|
| 09:00 ET |
CEL-SCI Receives Phase III Clinical Trial Go-Ahead for Cancer Drug
|
|
Aug 15, 05
|
| 16:30 ET |
CEL-SCI Corporation Reports Second Quarter 2005 Financial Results
|
|
Aug 12, 05
|
| 09:00 ET |
The American Stock Exchange Approves Plan Submitted by CEL-SCI
|
|
Jul 19, 05
|
| 10:00 ET |
CEL-SCI Raises $0.5 Million in New Equity
|
|
Jun 24, 05
|
| 16:55 ET |
CEL-SCI Receives Notice From Amex Regarding Continued Listing Standards
|
|
Jun 01, 05
|
| 09:15 ET |
CEL-SCI Receives U.S. Patent on Pre-Sensitizing Cancer Prior to Treatment with Radiation and/or Chemotherapy
|
|
May 23, 05
|
| 16:15 ET |
CEL-SCI Corporation Reports Second Quarter 2005 Financial Results
|
|
May 20, 05
|
| 09:40 ET |
CEL-SCI Announces Publication of Phase II Cancer Trial Results in Journal of Clinical Oncology
|
|
May 16, 05
|
| 10:01 ET |
CEL-SCI Announces Presentation of Data Showing Significant Reduction in Incidence and Severity of Autoimmune Myocarditis
|
|
Apr 21, 05
|
| 11:00 ET |
CEL-SCI Concludes Annual Meeting
|
|
Apr 04, 05
|
| 10:00 ET |
CEL-1000 Peptide Effective Against Viral Encephalitis in Mice
|
|
Mar 30, 05
|
| 10:25 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Feb 14, 05
|
| 16:30 ET |
CEL-SCI Corporation Reports First Quarter Financial Results
|
|
Jan 13, 05
|
| 10:17 ET |
CEL-SCI Corporation Announces 2004 Financial Results
|
|
Jan 10, 05
|
| 10:15 ET |
CEL-SCI Corporation Releases Letter To Shareholders
|
|
Jan 04, 05
|
| 09:00 ET |
CEL-SCI Files Phase III Clinical Trial Application With FDA
|
|
Sep 09, 04
|
| 09:45 ET |
Multikine(R) Cancer Drug Lowers Cholesterol in Clinical Studies
|
|
Aug 16, 04
|
| 12:20 ET |
CEL-SCI Corporation Reports Financial Results
|
|
Jul 15, 04
|
| 08:45 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jun 22, 04
|
| 09:00 ET |
CEL-SCI Announces New Conference Webcast
|
|
Jun 15, 04
|
| 15:43 ET |
CEL-SCI's CEO Interviewed by CEOcast and WALL STREET REPORTER
|
|
Jun 08, 04
|
| 09:35 ET |
CEL-SCI's Latest Clinical Findings - A New Way to Defeat Cancer?
|
|
Jun 07, 04
|
| 09:03 ET |
CEL-SCI Publishes Phase II Clinical Trial Results at ASCO
|
|
May 12, 04
|
| 16:45 ET |
CEL-SCI Corporation Reports Second Quarter 2004 Financial Results
|
|
May 04, 04
|
| 10:00 ET |
CEL-SCI Completes $5.25 Million Equity Offering
|
|
Apr 28, 04
|
| 09:31 ET |
CEL-SCI Enters Agreement With U.S. Navy for Potential Malaria Drug
|
|
Mar 29, 04
|
| 09:20 ET |
Midas Research Initiates Coverage of CEL-SCI
|
|
Mar 19, 04
|
| 09:30 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Mar 11, 04
|
| 09:01 ET |
CEL-SCI Abstract Selected for Publication in the American Society of Clinical Oncology (ASCO) Proceedings
|
|
Mar 01, 04
|
| 09:07 ET |
CEL-SCI Announces Appointment of Senior Vice President of Regulatory Affairs
|
|
Feb 19, 04
|
| 09:01 ET |
CEL-SCI to Present at BIO CEO & Investor 2004 Conference
|
|
Feb 12, 04
|
| 17:10 ET |
CEL-SCI Corporation Reports First Quarter Financial Results
|
|
| 12:10 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jan 08, 04
|
| 09:45 ET |
CEL-SCI CORPORATION Releases Letter to Shareholders
|
|
Dec 17, 03
|
| 11:16 ET |
CEL-SCI Corporation Announces 2003 Financial Results
|
|
Dec 09, 03
|
| 09:00 ET |
U.S. Navy Presents New Malaria Findings With CEL-1000 Peptide
|
|
Dec 08, 03
|
| 08:00 ET |
CEL-SCI Announces New Conference Webcast
|
|
| 07:01 ET |
Study Demonstrates Multikine(R) Makes Tumor Cells Highly Susceptible to Radiation Therapy
|
|
Dec 02, 03
|
| 11:30 ET |
CEL-SCI Announces $2.5 Million Private Placement
|
|
Nov 17, 03
|
| 10:00 ET |
CEL-SCI to Present at Bio-Europe 2003 Conference
|
|
Nov 12, 03
|
| 09:01 ET |
CEL-SCI Announces Receipt of Compliance Notice From AMEX
|
|
Nov 07, 03
|
| 09:00 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Oct 20, 03
|
| 10:43 ET |
CEL-SCI to Present at Rodman & Renshaw Techvest Healthcare Conference
|
|
Oct 07, 03
|
| 09:00 ET |
CEL-SCI Announces Conversion of Convertible Debt Into Common Stock
|
|
Sep 29, 03
|
| 08:12 ET |
CEL-SCI Gets Government Grant to Develop CEL-1000 Against Small Pox
|
|
Sep 25, 03
|
| 09:15 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Sep 23, 03
|
| 09:00 ET |
CEL-SCI Publishes Protection Data Against Herpes in Animals
|
|
Sep 18, 03
|
| 08:45 ET |
CEL-SCI Announces $10 Million Equity Financing Agreement
|
|
Sep 15, 03
|
| 08:45 ET |
CEL-SCI Presents Mechanism of Action Data for Protection Against Herpes Following CEL-1000 Pre-Treatment
|
|
Sep 08, 03
|
| 09:15 ET |
CEL-SCI to Present on Informed Investor Biotech Webcast
|
|
Aug 21, 03
|
| 09:02 ET |
CEL-SCI Reports Publication by Dr. R. Feinmesser of Clinical Data With Multikine(R) in Head & Neck Cancer Patients
|
|
Aug 15, 03
|
| 09:00 ET |
CEL-SCI Corporation Reports Financial Results
|
|
Jul 28, 03
|
| 09:20 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jul 22, 03
|
| 09:00 ET |
CEL-SCI Joins With HIV Advocates, HPV Foundation and Chronimed To Form The National HPV Co-Infection Alliance
|
|
Jul 14, 03
|
| 09:01 ET |
CEL-SCI Files Patent Application for Multikine(R) Drug to Enhance Radiation and Chemotherapy
|
|
Jul 09, 03
|
| 09:45 ET |
CEL-SCI Reports Acceptance for Publication by Peer-Reviewed Journal Of Important Novel Findings for the Treatment of Cancer
|
|
Jun 25, 03
|
| 09:35 ET |
CEL-SCI Files Patent Application for Drug to Target SARS and West Nile Virus
|
|
Jun 23, 03
|
| 11:39 ET |
CEL-SCI Signs Agreement With National Institutes of Health and U.S. Army For Testing of CEL-1000 Against SARS, Smallpox, Vaccinia and West Nile Virus
|
|
Jun 18, 03
|
| 13:36 ET |
CEL-SCI Receives Funds From Strategic Partner Investment
|
|
Jun 16, 03
|
| 08:45 ET |
CEL-SCI Reports Acceptance of Herpes Protection Data in Animals For Publication by Peer-Reviewed Journal
|
|
Jun 05, 03
|
| 08:30 ET |
CEL-SCI Reports on Adjuvant Properties of CEL-1000 Peptide to Enhance Vaccines
|
|
Jun 03, 03
|
| 09:02 ET |
CEL-SCI Receives New U.S. Patent for Herpes Simplex
|
|
Jun 02, 03
|
| 08:31 ET |
CEL-SCI Signs Strategic Partner Agreement
|
|
May 21, 03
|
| 16:15 ET |
CEL-SCI Corporation Reports Second Quarter 2003 Financial Results
|
|
May 15, 03
|
| 12:38 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
May 08, 03
|
| 09:03 ET |
CEL-SCI's CEO Interviewed by CEOcast and Wall Street Reporter
|
|
May 07, 03
|
| 09:01 ET |
CEL-SCI Receives Government Grant to Develop CEL-1000 Against Herpes
|
|
May 05, 03
|
| 09:01 ET |
CEL-SCI President and CEO Express Confidence in Company
|
|
Apr 30, 03
|
| 08:40 ET |
CEL-SCI Responds to Questions on SARS
|
|
| 08:30 ET |
CEL-SCI and Northeastern Ohio Universities College of Medicine Present CEL-1000 Peptide Data at the 16th International Conference on Antivirial Research
|
|
Apr 23, 03
|
| 09:02 ET |
CEL-SCI Receives NIH Research Grant to Develop New Treatment for Heart Disease
|
|
Apr 04, 03
|
| 16:15 ET |
Northeastern Ohio Universities College of Medicine and CEL-SCI Share $1.1 Million U.S. Government Grant for Development Of CEL-1000 Against Viral Encephalitis
|
|
Mar 12, 03
|
| 14:59 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Feb 14, 03
|
| 18:14 ET |
CEL-SCI Corporation Reports First Quarter Financial Results
|
|
Jan 29, 03
|
| 13:15 ET |
CEL-SCI's New Compound CEL-1000 - A Potential Agent Against Bio-Terrorism
|
|
Jan 21, 03
|
| 16:16 ET |
CEL-SCI CORPORATION Releases Letter to Shareholders
|
|
Jan 10, 03
|
| 16:15 ET |
CEL-SCI Corporation Announces 2002 Financial Results and $1.35 Million in New Funding
|
|
Dec 10, 02
|
| 11:11 ET |
CEL-SCI Enters Agreement With University of Arkansas Medical Center For Evaluation of CEL-1000 Against Genital Chlamydia
|
|
Nov 18, 02
|
| 16:05 ET |
CEL-SCI Enters Agreement With Proxima Concepts For Development of Oral Forms of CEL-1000 Compound
|
|
Oct 30, 02
|
| 09:00 ET |
CEL-SCI's CEO Chosen to Represent Biotech Industry At the Greater Washington Initiative Meetings in Germany
|
|
Oct 15, 02
|
| 10:07 ET |
CEL-SCI Corporation Announces Full Enrollment of Phase II Clinical Trial in Head & Neck Cancer
|
|
Oct 02, 02
|
| 11:49 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Sep 26, 02
|
| 10:03 ET |
CEL-SCI Enters Agreement With Cincinnati Children's Hospital Medical Center For Evaluation of New Compound Against Herpes
|
|
Sep 18, 02
|
| 12:33 ET |
CEL-SCI Enters Agreement With U.S. Navy for Evaluation Of New Malaria Compound
|
|
Sep 06, 02
|
| 10:31 ET |
CEL-SCI Responds to Malaria Update Requests Following Local Malaria Infections
|
|
Aug 21, 02
|
| 09:31 ET |
CEL-SCI Corporation Announces New Board of Directors Member
|
|
Aug 15, 02
|
| 12:50 ET |
CEL-SCI Corporation Reports Financial Results
|
|
Jul 17, 02
|
| 09:01 ET |
CEL-SCI Corporation Announces New Funding
|
|
Jul 15, 02
|
| 16:30 ET |
The American Stock Exchange Approves Plan Submitted by CEL-SCI
|
|
May 20, 02
|
| 12:00 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
May 13, 02
|
| 16:40 ET |
CEL-SCI Corporation Reports Financial Results
|
|
May 09, 02
|
| 09:00 ET |
Publication of Research Supporting Use of HSV Animal Model Announced
|
|
May 01, 02
|
| 09:00 ET |
CEL-SCI Announces That Its derG Peptide Protects Against Malaria in Mice
|
|
Apr 25, 02
|
| 08:34 ET |
Protection Results Against Malaria, Herpes and Cancer Reported With CEL-SCI's Newly Discovered Peptide
|
|
Apr 23, 02
|
| 09:01 ET |
Scientists From The Johns Hopkins Medical Institutions and CEL-SCI Present Results in Autoimmune Disease Research
|
|
Apr 16, 02
|
| 10:28 ET |
CEL-SCI Announces Discovery of Novel Compound With Very Broad Activity
|
|
Apr 11, 02
|
| 14:12 ET |
With Completion of Manufacturing Validation Program, CEL-SCI Significantly Reduces Expenditures
|
|
Apr 09, 02
|
| 10:06 ET |
CEL-SCI Corporation Announces Initial Long-Term Survival Findings From Ongoing Head & Neck Cancer Study
|
|
Apr 03, 02
|
| 09:01 ET |
CEL-SCI Corporation Invites You to Join Its Webcast at the American Stock Exchange Online Conference
|
|
Mar 25, 02
|
| 09:00 ET |
Herpes Vaccine From CEL-SCI Corporation Demonstrated to Be Protective in New Animal Model
|
|
Mar 19, 02
|
| 09:02 ET |
Multikine(TM) Demonstrates Excellent Clinical Responses In HIV-Infected Women With Cervical Dysplasia
|
|
Mar 14, 02
|
| 09:02 ET |
CEL-SCI'S L.E.A.P.S.(TM) Technology Presented at SMi Conference On Immune Disorders
|
|
Mar 01, 02
|
| 16:56 ET |
CEL-SCI Corporation Reports First Quarter Results
|
|
Feb 12, 02
|
| 08:31 ET |
CEL-SCI Will Be Presenting at the Wall Street Analyst Forum On February 14, 2002
|
|
Feb 04, 02
|
| 08:33 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jan 28, 02
|
| 09:01 ET |
CEL-SCI Announces Receipt of Financing
|
|
Jan 16, 02
|
| 09:01 ET |
CEL-SCI Extends Warrant Date
|
|
Jan 14, 02
|
| 08:30 ET |
CEL-SCI's L.E.A.P.S.(TM) Technology Shows Protection Against A Serious Heart Disease in Animal Model
|
|
Jan 09, 02
|
| 08:30 ET |
Presentation on CEL-SCI's Multikine(TM) Drug to Be Presented At the Society of Gynecologic Oncologists Annual Meeting
|
|
Jan 07, 02
|
| 08:55 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Jan 04, 02
|
| 16:45 ET |
CEL-SCI Corporation Announces 2001 Financial Results And $1.6 Million in New Funding
|
|
Dec 05, 01
|
| 12:30 ET |
CEL-SCI Corporation Announces Publication of Promising Preclinical Results
|
|
Nov 28, 01
|
| 08:40 ET |
CEL-SCI Announces Financing of More Than $2.2 Million
|
|
Oct 30, 01
|
| 11:00 ET |
Dr. Edmund Tramont, Director of the Division of AIDS at NIAID/NIH, Presents Significant Clinical Data With CEL-SCI Drug in HIV-Infected Women With Human Papilloma Virus (HPV) Induced Cervical Dysplasia
|
|
Oct 24, 01
|
| 09:04 ET |
CEL-SCI Signs Joint Development Agreement With Biomedex To Develop a Faster Test for Anthrax in Humans
|
|
Oct 22, 01
|
| 11:27 ET |
CEL-SCI to Present Company Update at the Techvest 3rd Annual Healthcare Conference
|
|
Oct 09, 01
|
| 08:32 ET |
Multikine(TM) Demonstrates Excellent Clinical Responses in HIV-Infected Women With Human Papilloma Virus (HPV) Induced Cervical Dysplasia
|
|
Sep 24, 01
|
| 09:25 ET |
CEL-SCI Corporation Announces Clinical Data To Be Presented in October at the Annual Meeting Of The International Society for Interferon and Cytokine Research
|
|
Sep 19, 01
|
| 09:01 ET |
CEL-SCI Corporation Announces Issuance of Three New U.S. Patents Covering HIV Immunotherapeutic Agents
|
|
Sep 17, 01
|
| 10:04 ET |
CEL-SCI Corporation Extends Agreement With U.S. Navy for Malaria Vaccine Collaboration
|
|
Sep 07, 01
|
| 09:03 ET |
CEL-SCI Corporation Reports Promising Preclinical Results With Potential HIV Immunotherapeutic Agent
|
|
Aug 14, 01
|
| 16:05 ET |
CEL-SCI Corporation Reports Financial Results
|
|
Jul 24, 01
|
| 10:45 ET |
CEL-SCI Gives Update on Cervical Cancer Clinical Trial
|
|
Jul 19, 01
|
| 09:03 ET |
CEL-SCI Extends Warrant Date
|
|
Jun 15, 01
|
| 10:00 ET |
CEL-SCI to Present at Amex Online Conference
|
|
May 31, 01
|
| 11:12 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
May 11, 01
|
| 16:00 ET |
CEL-SCI Corporation Reports Financial Results
|
|
May 07, 01
|
| 12:00 ET |
CEL-SCI to Start Cervical Cancer Study at Institute of Human Virology; Institute of Human Virology Set to Begin Cervical Cancer Clinical Trial
|
|
Apr 12, 01
|
| 09:01 ET |
CEL-SCI Announces $10 Million Equity Financing Facility
|
|
Mar 27, 01
|
| 09:02 ET |
CEL-SCI Corporation Announces Change in its Board of Directors
|
|
Feb 16, 01
|
| 16:15 ET |
CEL-SCI CORPORATION Reports First Quarter Results
|
|
Feb 13, 01
|
| 13:41 ET |
CEL-SCI Corporation Releases Annual Report With Letter to Shareholders
|
|
Jan 29, 01
|
| 08:59 ET |
CEL-SCI Corporation Renews and Extends Agreement With National Cancer Institute for Cancer Collaboration
|
|
Jan 18, 01
|
| 12:43 ET |
CEL-SCI Responds to Shareholder Inquiries on Paper Published by Scripps Research Institute Scientists
|
|
| 09:01 ET |
CEL-SCI Extends Warrant Date and Changes Term of Warrants
|
|
Jan 16, 01
|
| 09:01 ET |
Dirty Dozen Research Group Initiates Coverage Of CEL-SCI Corporation With a Buy Recommendation
|
|
Jan 04, 01
|
| 08:59 ET |
CEL-SCI Corporation Receives Permission to Start Phase II Cancer Study In Mexico
|
|
Jan 03, 01
|
| 11:35 ET |
CEL-SCI Corporation Reports 2000 Financial Results
|
|
Nov 20, 00
|
| 09:14 ET |
CEL-SCI Signs Development, Supply and Distribution Agreement for Multikine(TM) Cancer Drug
|
|
Nov 14, 00
|
| 08:42 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
Oct 31, 00
|
| 09:00 ET |
Protection Against Malaria in Animals Reported at Scientific Conference
|
|
Oct 24, 00
|
| 10:30 ET |
CEL-SCI Sends Letter to Management of Molecular Biosystems, Inc.
|
|
Oct 03, 00
|
| 09:23 ET |
CEL-SCI Receives Grant From the National Institute of Allergy And Infectious Diseases to Develop a Herpes Simplex Vaccine
|
|
Sep 14, 00
|
| 08:59 ET |
UMBI and CEL-SCI Corporation Receive Grant For Cervical Cancer Human Study
|
|
Sep 07, 00
|
| 10:04 ET |
CEL-SCI Corporation Announces Issuance of Two New U.S. Patents on Vaccine Technology
|
|
Sep 05, 00
|
| 09:28 ET |
CEL-SCI Corporation Extends Agreement With U.S. Navy For Malaria Vaccine Collaboration
|
|
Aug 29, 00
|
| 09:03 ET |
Cel-Sci Corporation Hires New Senior Director of Laboratory and Manufacturing Operations
|
|
Aug 21, 00
|
| 08:59 ET |
CEL-SCI Corporation Receives Permission To Start Phase II Cancer Study in Czech Republic
|
|
Aug 15, 00
|
| 10:54 ET |
CEL-SCI Corporation Reports Financial Results
|
|
Aug 08, 00
|
| 09:30 ET |
CEL-SCI Corporation Significantly Expands Facilities
|
|
Aug 03, 00
|
| 06:02 ET |
Researcher Presents Clinical Findings on CEL-SCI's Multikine(TM) at 5th International Congress on Head and Neck Cancer
|
|
Jul 31, 00
|
| 09:30 ET |
CEL-SCI Corporation Announces Issuance of Key U.S. Patent on Vaccine Technology
|
|
Jul 12, 00
|
| 09:02 ET |
CEL-SCI Corporation Receives Permission to Start Phase II Cancer Study in Poland
|
|
Jun 30, 00
|
| 06:00 ET |
HIV-Infected Patients Treated With CEL-SCI's Multikine(TM) Show Evidence Of Improved Cell-Mediated Immunity
|
|
Jun 28, 00
|
| 09:00 ET |
CEL-SCI Corporation Receives Permission To Start Phase II Cancer Study in Canada
|
|
Jun 21, 00
|
| 09:01 ET |
CEL-SCI Corporation Secures Long-Term Manufacturing Commitment for Multikine(TM)
|
|
Jun 15, 00
|
| 10:00 ET |
CEL-SCI Corporation Starts Another Collaboration With the National Cancer Institute
|
|
Jun 06, 00
|
| 09:01 ET |
CEL-SCI Corporation Announces In Vitro Data On Serum Samples From South African AIDS Infected Patients
|
|
May 23, 00
|
| 11:49 ET |
CEL-SCI Receives Permission to Start Breast Cancer Study in Israel
|
|
May 15, 00
|
| 17:30 ET |
CEL-SCI Corporation Reports Financial Results
|
|
| 10:38 ET |
CEL-SCI Corporation Releases Letter to Shareholders
|
|
May 08, 00
|
| 11:34 ET |
CEL-SCI Corporation Reports Promising Results in Phase II Cancer Study
|
|
May 02, 00
|
| 10:00 ET |
CEL-SCI's Herpes Vaccine Protective in Animal Model
|
|
May 01, 00
|
| 10:01 ET |
CEL-SCI Offers South African Government a Free License to its AIDS Vaccine
|
|
Mar 24, 00
|
| 09:00 ET |
CEL-SCI Completes Equity Financing
|
|
Mar 16, 00
|
| 12:50 ET |
CEL-SCI Completes Equity Financing
|
|
Mar 02, 00
|
| 09:02 ET |
CEL-SCI Announces Novel Vaccine Candidate for the Treatment of HIV
|
|
Feb 15, 00
|
| 10:30 ET |
CEL-SCI Corporation Reports Promising Results of Phase II Cancer Study; Multikine(TM) Immunotherapy Study Presented at BIO CEO & Investor Conference
|
|
Feb 14, 00
|
| 09:01 ET |
CEL-SCI Corporation Reports First Quarter Results
|
|
Feb 07, 00
|
| 08:01 ET |
CEL-SCI Corporation Has New Stock Symbol
|
|
Feb 03, 00
|
| 11:59 ET |
CEL-SCI Corporation Changes Stock Symbol
|
|
Jan 31, 00
|
| 09:01 ET |
University of Maryland and CEL-SCI Corporation Receive Second Grant for Tuberculosis Vaccine
|
|
Jan 25, 00
|
| 09:01 ET |
CEL-SCI Corporation Retains Investor Relations Firm
|
|
Jan 13, 00
|
| 09:00 ET |
CEL-SCI Corporation Extends Warrant Date
|
|
Jan 05, 00
|
| 12:50 ET |
Johns Hopkins University and CEL-SCI Corporation Receive Grant for Novel Heart Disease Research
|
|
Dec 30, 99
|
| 09:00 ET |
CEL-SCI Corporation Reports 1999 Financial Results
|
|
Dec 14, 99
|
| 09:00 ET |
CEL-SCI Completes Equity Financing
|
|
Dec 02, 99
|
| 08:59 ET |
CEL-SCI Corporation Announces Completion of Another Cancer Study
|
|
Nov 22, 99
|
| 09:01 ET |
CEL-SCI Announces Data from Phase II HIV Vaccine Study
|
|
Nov 19, 99
|
| 09:01 ET |
CEL-SCI Starts Cancer Collaboration in Germany
|
|
Nov 15, 99
|
| 11:53 ET |
CEL-SCI Corporation Collaborates With Johns Hopkins University Researchers for Heart Disease
|
|
Nov 08, 99
|
| 09:03 ET |
CEL-SCI CORPORATION Announces Full Enrollment of Cancer Study
|
|
Nov 05, 99
|
| 09:00 ET |
CEL-SCI Corporation Hires New Senior Director of Quality Assurance
|
|
Oct 19, 99
|
| 09:12 ET |
CEL-SCI Reports Encouraging Clinical Findings in HIV-Infected Patients
|
|
Oct 11, 99
|
| 09:01 ET |
Herpes Vaccine Protective in Animals
|
|
Sep 27, 99
|
| 08:30 ET |
CEL-SCI Corporation Forms New Company
|
|
Sep 20, 99
|
| 16:00 ET |
CEL-SCI Corporation Sends Letter to Shareholders
|
|
Aug 18, 99
|
| 17:20 ET |
CEL-SCI Corporation Responds to News Reports Concerning Offer to Purchase Shares of Common Stock
|
|
Aug 16, 99
|
| 08:30 ET |
CEL-SCI Corporation Reports June Quarterly Results And Updates Investors on Cancer Therapy's Clinical Trial Progress
|
|
May 17, 99
|
| 08:30 ET |
CEL-SCI Corporation Reports Financial Results and Management is Encouraged By the Progress in the Development of its Cancer Drug Multikine(TM)
|
|
Apr 19, 99
|
| 08:31 ET |
CEL-SCI Corporation Announces New Web Site
|
|
Apr 13, 99
|
| 08:30 ET |
CEL-SCI Corporation Announces Results of Shareholder Meeting
|
|
Apr 12, 99
|
| 09:30 ET |
CEL-SCI Shareholder Letter
|
|
Mar 25, 99
|
| 08:31 ET |
CEL-SCI Corporation Announces Start of Phase II Cancer Study
|
|
Mar 22, 99
|
| 08:30 ET |
CEL-SCI Reports Important Results in Israeli Clinical Trial; Re-Analysis Shows Enhanced Benefits
|
|
Mar 15, 99
|
| 08:31 ET |
CEL-SCI Announces Start of Prostate Cancer Study
|
|
Mar 04, 99
|
| 08:30 ET |
CEL-SCI Receives Permission to Start Phase II Cancer Study in Czech Republic
|
|
Feb 12, 99
|
| 08:30 ET |
CEL-SCI Corporation Reports First Quarter 1999 Results
|
|
Feb 09, 99
|
| 08:59 ET |
Thomas Jefferson University Hospital and CEL-SCI Corporation to Start Prostate Cancer Study
|
|
Jan 28, 99
|
| 08:31 ET |
Herpes Vaccine Effective in Animals
|
|
Jan 25, 99
|
| 08:30 ET |
CEL-SCI Corporation to Start Cancer Study in Israel
|
|
Jan 21, 99
|
| 08:30 ET |
State of Maryland Funds Tuberculosis Vaccine
|
|
Jan 15, 99
|
| 08:30 ET |
AIDS Vaccine Shows Promising Cellular Immune Responses
|
|
Jan 14, 99
|
| 08:31 ET |
CEL-SCI Corporation Reports 1998 Financial Results
|
|
Jan 13, 99
|
| 08:31 ET |
New Findings Support CEL-SCI's Aids Vaccine Approach
|
|
Jan 08, 99
|
| 09:00 ET |
CEL-SCI Corporation Receives Permission To Start Phase II Cancer Study in Poland
|
|
Dec 03, 98
|
| 08:30 ET |
CEL-SCI Corporation Announces Permission to Start Phase II Cancer Study in Hungary
|
|
Dec 01, 98
|
| 17:38 ET |
The Politics of AIDS Vaccines In the Developing World
|
|
Oct 20, 98
|
| 08:30 ET |
CEL-SCI Corporation and University of Nebraska Announce Research Grant With HGP-30 AIDS Vaccine
|
|
Oct 05, 98
|
| 08:30 ET |
AIDS Vaccine Effective in Animal Tests
|
|
Sep 14, 98
|
| 13:37 ET |
Aids Vaccine Technology Brief
|
|
Aug 11, 98
|
| 08:30 ET |
CEL-SCI Corporation Reports Third Quarter 1998 Results
|
|
Aug 06, 98
|
| 08:30 ET |
CEL-SCI's Herpes Vaccine Shows Protection Against Herpes Infection in Animals
|
|
Aug 03, 98
|
| 08:30 ET |
CEL-SCI Adds New Member to Scientific Advisory Board
|
|
Jul 28, 98
|
| 08:32 ET |
CEL-SCI Corporation Extends Agreement with U.S. Navy For Malaria Vaccine Collaboration
|
|
Jul 27, 98
|
| 08:27 ET |
CEL-SCI Aware of No Developments to Account for Recent Stock Activity
|
|
Jul 22, 98
|
| 08:33 ET |
CEL-SCI Corporation Completes Enrollment of Phase II AIDS Vaccine Study
|
|
Jul 20, 98
|
| 08:31 ET |
State of Maryland Funds Second Phase of Cel-Sci's Development of a Diagnostic Test for Tuberculosis
|
|
Jun 25, 98
|
| 08:31 ET |
CEL-SCI Corporation Starts Phase II Trial with HGP-30W AIDS Vaccine
|
|
Jun 22, 98
|
| 08:30 ET |
Business Development Officer Joins CEL-SCI Corporation
|
|
Jun 17, 98
|
| 08:01 ET |
CEL-SCI Corp. Receives Approval for Groundbreaking Phase II AIDS Vaccine Study in Europe
|
|
Jun 08, 98
|
| 10:33 ET |
Promising Treatment for Head and Neck Cancer Demonstrates Encouraging Results in Clinical Trial
|
|
Jun 05, 98
|
| 09:54 ET |
CEL-SCI Corporation Announces New Address and Phone Number
|
|
Jun 02, 98
|
| 08:02 ET |
Improved AIDS Vaccine Recognizes Most Prevalent Strains of the Virus
|
|
May 29, 98
|
| 12:47 ET |
CEL-SCI Corporation Announces Results of Annual Meeting
|
|
May 27, 98
|
| 08:31 ET |
CEL-SCI Corporation Announces Research Grant for Its Herpes Simplex Vaccine
|
|
May 15, 98
|
| 08:30 ET |
CEL-SCI Corporation Reports Second Quarter 1998 Results
|
|
May 06, 98
|
| 08:30 ET |
CEL-SCI Corporation Announces Promising Clinical Trial Results in Cancer Patients
|
|
| 08:30 ET |
CEL-SCI Corporation Announces Promising Clinical Trial Results in Cancer Patients
|
|
May 05, 98
|
| 17:53 ET |
/K I L L K I L L K I L L -- CEL-SCI Corporation/
|
|
| 17:47 ET |
CEL-SCI Corporation Completes Enrollment of AIDS Therapeutic Safety Study
|
|
| 00:00 ET |
CEL-SCI Corporation Completes Enrollment of AIDS Therapeutic Safety Study
|
|
Apr 07, 98
|
| 08:27 ET |
CEL-SCI Corporation Introduces L.E.A.P.S. Technology at Scientific Conference
|
|
Mar 17, 98
|
| 08:31 ET |
CEL-SCI Corporation Expands Clinical Trial for Cancer in U.S.
|
|
Mar 09, 98
|
| 08:28 ET |
Animal Studies With HGP-30 AIDS Vaccine Show Important Responses for Worldwide AIDS Vaccine
|
|
Feb 26, 98
|
| 08:30 ET |
CEL-SCI Corporation Approved for Trading on Berlin Stock Exchange
|
|
Feb 25, 98
|
| 08:31 ET |
CEL-SCI Corporation Extends Warrant Date
|
|
Feb 10, 98
|
| 08:30 ET |
CEL-SCI Corporation Reports First Quarter 1998 Results
|
|
Feb 02, 98
|
| 12:03 ET |
CEL-SCI Corporation Sends Letter to Shareholders
|
|
Jan 27, 98
|
| 08:30 ET |
CEL-SCI Corporation Announces Change in Terms of its Publicly Held Warrants
|
|
Dec 29, 97
|
| 13:44 ET |
CEL-SCI Corporation Reports Fiscal Year 1997 Results
|
|
Dec 23, 97
|
| 12:52 ET |
CEL-SCI Corporation Completes $10 Million Financing
|
|
Dec 17, 97
|
| 10:44 ET |
CEL-SCI Corporation Signs Final Agreement With National Cancer Institute For Cancer Collaboration
|
|
Dec 10, 97
|
| 08:28 ET |
AIDS Vaccine Effective in Animal Tests; Human HGP-30 Antibodies Shown to Recognize HIV Subtypes
|
|
Dec 03, 97
|
| 08:31 ET |
CEL-SCI Corporation Expands Clinical Trial for Cancer in Canada
|
|
Nov 18, 97
|
| 08:31 ET |
CEL-SCI Corporation Announces Improvement In Terms of its Publicly Held Warrants
|
|
Oct 29, 97
|
| 08:31 ET |
CEL-SCI Corporation Announces Issuance of Canadian Patent on L.E.A.P.S. Vaccine Technology
|
|
Oct 23, 97
|
| 12:25 ET |
CEL-SCI Corporation Responds to Inquiries About the Status of Its Tuberculosis Program
|
|
Oct 20, 97
|
| 08:31 ET |
CEL-SCI Corporation Ends Patent Lawsuit Against Immuno-Rx and Dr. Hadden
|
|
Oct 14, 97
|
| 09:44 ET |
CEL-SCI CORPORATION Announces Research Grant With HGP-30 AIDS Vaccine
|
|
Oct 06, 97
|
| 08:30 ET |
CEL-SCI Corporation Announces Clinical Trial Results In Head and Neck Cancer Patients
|
|
Sep 29, 97
|
| 09:02 ET |
CEL-SCI Corporation's Herpes Simplex Vaccine Protects Mice Against Herpes Infection
|
|
Sep 22, 97
|
| 09:04 ET |
CEL-SCI Corporation Signs Agreement With National Cancer Institute For Cancer Collaboration
|
|
Sep 17, 97
|
| 08:30 ET |
CEL-SCI Corporation and AIDS ReSEARCH Alliance Announce Results of HGP-30 AIDS Vaccine Study, Plan Further Study
|
|
Sep 10, 97
|
| 08:31 ET |
CEL-SCI Corporation Starts New Cancer Trial in Canada
|
|
Sep 08, 97
|
| 08:34 ET |
CEL-SCI Corporation Announces Completion of Prostate Cancer Safety Study; Plans to Start a Further Study
|
|
Sep 03, 97
|
| 08:31 ET |
U.S. Patent Office Allows Patent to CEL-SCI Corporation on AIDS Diagnostic Kit
|
|
Aug 25, 97
|
| 08:31 ET |
American Red Cross and CEL-SCI Corporation Enter Into A Long-Term Supply Agreement
|
|
Aug 15, 97
|
| 09:02 ET |
CEL-SCI Corporation Reports Third Quarter 1997 Results
|
|
Jul 29, 97
|
| 08:29 ET |
CEL-SCI Corporation Announces Issuance of U.S. Patent on Promising Immune System Technology
|
|
Jul 08, 97
|
| 08:26 ET |
CEL-SCI Corporation Announces Development of a Potential AIDS Vaccine For Worldwide Use
|
|
Jun 10, 97
|
| 17:03 ET |
CEL-SCI Corporation Common Stock and Warrants Trade on AMEX
|
|
| 08:29 ET |
CEL-SCI CORPORATION Announces Permission to Start Cancer Study in Canada
|
|
Jun 03, 97
|
| 12:15 ET |
CEL-SCI Corporation Announces Results of Annual Meeting and Plans to Shift to AMEX
|
|
| 08:29 ET |
AIDS ReSEARCH ALLIANCE and CEL-SCI Corporation Announce Start of HIV Study with Multikine(TM)
|
|
May 19, 97
|
| 09:59 ET |
President Clinton's National Goal of Finding an AIDS Vaccine Strongly Endorsed by CEL-SCI Corporation
|
|
May 08, 97
|
| 11:58 ET |
CEL-SCI Corporation Changes Price and Terms of Conversion Of Its Publicly Held Warrants
|
|
May 05, 97
|
| 08:32 ET |
HGP-30 AIDS Vaccine Shows Recognition of Major HIV Subtypes in Human and Animal Studies
|
|
Apr 22, 97
|
| 08:33 ET |
CEL-SCI Corporation Starts Cancer Trial in Israel
|
|
Apr 01, 97
|
| 08:28 ET |
CEL-SCI Makes Final Payment for Vaccine Technology
|
|
Mar 20, 97
|
| 08:29 ET |
CEL-SCI Corporation Announces Permission to Start Cancer Study in Israel
|
|
Mar 10, 97
|
| 08:30 ET |
CEL-SCI Announces The Purchase of The Patents and License Rights to Its Immunotherapy Drug Multikine(TM)
|
|
Jan 27, 97
|
| 08:31 ET |
CEL-SCI Corporation Presents Preclinical Data on Potential AIDS Immunotherapy
|
|
Jan 15, 97
|
| 08:30 ET |
CEL-SCI Gets Award From State of Maryland to Develop a Diagnostic Test for Tuberculosis
|
|
Jan 08, 97
|
| 08:06 ET |
Key Product Patent for CEL-SCI Issued By Japanese Patent Office
|
|
Jan 06, 97
|
| 08:29 ET |
AIDS Research Alliance and CEL-SCI Corporation Announce FDA Clearance for AIDS Trial With Multikine(TM)
|
|
Dec 23, 96
|
| 09:01 ET |
CEL-SCI Repurchases $2.85 Million of Its Stock
|
|
Dec 09, 96
|
| 09:03 ET |
CEL-SCI Corporation Extends Warrant Date
|
|
Nov 13, 96
|
| 08:31 ET |
Japanese Patent Office Issues Patent To CEL-SCI Corporation on Aids Diagnostic Kit
|
|
Oct 30, 96
|
| 08:31 ET |
CEL-SCI CORPORATION Announces Interim Results of HGP-30 AIDS Vaccine Study
|
|
Oct 01, 96
|
| 08:31 ET |
CEL-SCI Corporation And N.E. Ohio U. College Of Medicine To Work On Herpes Virus Vaccine
|
|
Sep 18, 96
|
| 09:33 ET |
Three Additional Centers Begin Clinical Testing of CEL-SCI's Anti-Tumor Drug Multikine(TM)
|
|
Aug 19, 96
|
| 09:01 ET |
CEL-SCI Raises $5.0 Million
|
|
Aug 12, 96
|
| 08:30 ET |
CEL-SCI CORPORATION SIGNS AGREEMENT WITH U.S. NAVY FOR MALARIA VACCINE COLLABORATION
|
|
Aug 05, 96
|
| 12:14 ET |
CEL-SCI Corporation Responds to Dow Jones Story
|
|
| 12:02 ET |
CEL-SCI Corporation Responds to Dow Jones Story
|
|
Jul 25, 96
|
| 08:30 ET |
CEL-SCI CORPORATION ANNOUNCES PUBLICATION OF TWO SCIENTIFIC ARTICLES
|
|
Jul 22, 96
|
| 08:30 ET |
CEL-SCI CORPORATION PURCHASES ALL REMAINING RIGHTS TO HGP-30 AIDS VACCINE FROM FORMER JAPANESE PARTNER
|
|
Jul 17, 96
|
| 08:30 ET |
CEL-SCI CORPORATION LOWERS EXERCISE PRICE OF PUBLICLY HELD WARRANTS
|
|